STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network

Marc J Claeys1, Peter R Sinnaeve, Carl Convens

  • 1University Hospital Antwerp, Edegem, Belgium.

Insights

This study found that ST elevation myocardial infarction (STEMI) networks achieved comparable in-hospital mortality rates between community and PCI-capable hospitals. Participation in STEMI networks improved adherence to reperfusion guidelines over time.

Area of Science:

  • Cardiology
  • Health Services Research

Background:

  • Existing ST elevation myocardial infarction (STEMI) networks primarily focus on percutaneous coronary intervention (PCI) times and outcomes.
  • Real-world data on the management and outcomes of unselected STEMI populations within these networks are limited.

Purpose of the Study:

  • To evaluate reperfusion strategies and in-hospital mortality in a nationwide STEMI network.
  • To assess the effectiveness of STEMI networks in community and PCI-capable hospitals.

Main Methods:

  • The study analyzed 8500 unselected STEMI patients across 47 community and 25 PCI-capable hospitals in Belgium.
  • Propensity score analysis was used to adjust for baseline differences between patient groups.
  • Reperfusion strategies (primary PCI vs. thrombolysis) and door-to-balloon times were compared.

Main Results:

  • Primary PCI was predominantly used in PCI-capable hospitals (93%) compared to community hospitals (71%).
  • Door-to-balloon times <120 min were achieved in 83% of community and 91% of PCI-capable hospitals.
  • In-hospital mortality was similar: 7.0% in community hospitals vs. 6.7% in PCI-capable hospitals (adjusted OR 1.1).
  • The rate of primary PCI in community hospitals increased from 60% to 80% between 2007-2008 and 2009-2010.

Conclusions:

  • STEMI networks with high primary PCI utilization (>70%) demonstrate comparable in-hospital mortality between community and PCI-capable facilities.
  • Network participation correlated with improved adherence to reperfusion guidelines over time.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...